Patents by Inventor Mikel P. Moyer

Mikel P. Moyer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CAFFEINE INHIBITORS OF MTHFD2 AND USES THEREOF
    Publication number: 20230067237
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Application
    Filed: January 19, 2022
    Publication date: March 2, 2023
    Inventors: Nello MAINOLFI, Mikel P. MOYER, Eddine SAIAH, Cristina LECCI, Robert David Matthew PACE, Heather TYE, Julia VILE
  • Caffeine inhibitors of MTHFD2 and uses thereof
    Patent number: 11370792
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Grant
    Filed: December 14, 2016
    Date of Patent: June 28, 2022
    Assignee: Raze Therapeutics, Inc.
    Inventors: Nello Mainolfi, Mikel P. Moyer, Eddine Saiah, Cristina Lecci, Robert David Matthew Pace, Heather Tye, Julia Vile
  • CAFFEINE INHIBITORS OF MTHFD2 AND USES THEREOF
    Publication number: 20180370972
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Application
    Filed: December 14, 2016
    Publication date: December 27, 2018
    Inventors: Nello Mainolfi, Mikel P. Moyer, Eddine Saiah, Cristina Lecci, Robert David Matthew Pace, Heather Tye, Julia Vile
  • INHIBITION OF HDAC2 TO PROMOTE MEMORY
    Publication number: 20120101147
    Abstract: The invention relates to methods and products for enhancing and improving recovery of lost memories. In particular the methods are accomplished by inhibiting HDAC2 and or selectively inhibiting HDAC1/2 or HDAC1/2/3.
    Type: Application
    Filed: December 2, 2009
    Publication date: April 26, 2012
    Applicant: The General Hospital Corporation d/b/a Massachusetts General Hospital
    Inventors: Li-Huei Tsai, Andre Fischer, Stephen J. Haggarty, Weiping Tang, Stuart L. Schreiber, Edward Holson, Florence Wagner, Mikel P. Moyer
  • Heterocyclic ring-fused pyrimidine derivatives
    Patent number: 6395733
    Abstract: The present invention relates to heterocyclic ring-fused pyrimidine derivatives of formula (I) or stereoisomers, pharmaceutically acceptable salts or prodrugs thereof, wherein Z and Y are as defined in the specification.
    Type: Grant
    Filed: November 9, 1999
    Date of Patent: May 28, 2002
    Assignee: Pfizer Inc
    Inventors: Lee Daniel Arnold, Mikel P. Moyer, Susan B. Sobolov-Jaynes
  • Quinoline derivatives as immunostimulants
    Patent number: 5506235
    Abstract: This invention relates to compounds of the formula ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6 and R.sup.7 are as defined hereinbelow that exhibit activity as immunostimulants.
    Type: Grant
    Filed: January 2, 1994
    Date of Patent: April 9, 1996
    Assignee: Pfizer Inc.
    Inventors: Mikel P. Moyer, James W. McFarland
  • Anaphylatoxin-receptor ligands
    Patent number: 5223485
    Abstract: Oligopeptide compounds or oligopeptide analogue compounds of the formula A-B-D-E-G-J-L-M-Q-T are ligands for the anaphylatoxin receptor and are useful in the treatment of inflammatory disease states. Also disclosed are anaphylatoxin receptor ligand compositions and a method for modulating anaphylatoxin activity.
    Type: Grant
    Filed: June 19, 1991
    Date of Patent: June 29, 1993
    Assignee: Abbott Laboratories
    Inventors: Megumi Kawai, Yat S. Or, Paul E. Wiedeman, Jay R. Luly, Mikel P. Moyer